ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $101,710 | +3692.3% | 17,658 | +5786.0% | 0.00% | – |
| Q4 2022 | $2,682 | -99.8% | 300 | -99.7% | 0.00% | -100.0% |
| Q3 2022 | $1,619,000 | -11.2% | 113,834 | -8.9% | 0.01% | -25.0% |
| Q2 2022 | $1,824,000 | -77.1% | 124,900 | -68.6% | 0.01% | -75.0% |
| Q1 2022 | $7,950,000 | -43.5% | 398,109 | -50.5% | 0.03% | -42.9% |
| Q4 2021 | $14,060,000 | +40.7% | 803,900 | -36.9% | 0.06% | +27.3% |
| Q3 2021 | $9,996,000 | -20.0% | 1,275,000 | +4.9% | 0.04% | -21.4% |
| Q2 2021 | $12,502,000 | -8.8% | 1,215,000 | +15.9% | 0.06% | -12.5% |
| Q1 2021 | $13,709,000 | – | 1,048,100 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |